1 Report Prologue
2 Executive Summary
3 Market Introduction
3.1 Definition 20
3.2 Scope of the Study 20
3.3 Research Objective 20
3.4 Assumptions & Limitations 20
3.4.1 Assumptions 20
3.4.2 Limitations 20
3.5 Market Structure 21
3.6 Research Process 21
4 Research Methodology
4.1 Primary Research 24
4.2 Secondary Research 25
4.3 Market Size Estimation 26
4.4 Forecast Model 26
5 Market Dynamics
5.1 Introduction 28
5.2 Drivers 28
5.2.1 Growing Demand for Organ Transplantation 28
5.2.2 Cost-Efficiency of 3D Bioprinting 28
5.2.3 Growing Focus of Market Players on 3D Bioprinting 29
5.2.4 Increasing Funding and Investments for Research 29
5.3 Restraints 29
5.3.1 Lack of Awareness Regarding 3D Bioprinting 29
5.3.2 Lack of Skilled Professionals 29
5.4 Opportunities 30
5.4.1 Dominance of Start-Ups 30
6 Market Factor Analysis
6.1 Porter’s Five Forces Model 32
6.1.1 Bargaining Power of Suppliers 32
6.1.2 Bargaining Power of Buyers 33
6.1.3 Threat of New Entrants 33
6.1.4 Threat of Substitutes 33
6.1.5 Rivalry 33
6.2 Supply Chain Analysis 34
6.2.1 R&D and Development 34
6.2.2 Manufacturing 34
6.2.3 Distribution & Sales 34
6.2.4 Post-Sales Monitoring 35
6.3 Investment Feasibility Analysis 35
6.4 Pricing Analysis 35
7 3D Bioprinting Market, by Technology
7.1 Introduction 37
7.2 Microextrusion Bioprinting 38
7.3 Inkjet 3D bioprinting 39
7.4 Laser-Assisted Bioprinting 39
7.5 Magnetic 3D Bioprinting 40
8 3D Bioprinting Market, by Material
8.1 Introduction 42
8.2 Living Cells 43
8.3 Hydrogels 44
8.4 Extracellular Matrices 44
9 3D Bioprinting Market, by Application
9.1 Introduction 47
9.2 Research Applications 48
9.3 Clinical Applications 51
10 3D Bioprinting Market, by End User
10.1 Introduction 54
10.2 Pharmaceutical & Biotechnology Companies 55
10.3 Research Organizations & Academic Institutes 56
11 Global 3D Bioprinting Market, by Region
11.1 Introduction 58
11.2 Americas 60
3D Bioprinting Market, by Technology
3D Bioprinting Market, by Material
3D Bioprinting Market, by Application
3D Bioprinting Market, by End User
11.2.1 North America 63
3D Bioprinting Market, by Technology
3D Bioprinting Market, by Material
3D Bioprinting Market, by Application
3D Bioprinting Market, by End User
11.2.1.1 US 67
3D Bioprinting Market, by Technology
3D Bioprinting Market, by Material
3D Bioprinting Market, by Application
3D Bioprinting Market, by End User
11.2.1.2 Canada 69
3D Bioprinting Market, by Technology
3D Bioprinting Market, by Material
3D Bioprinting Market, by Application
3D Bioprinting Market, by End User
11.2.2 South America 72
3D Bioprinting Market, by Technology
3D Bioprinting Market, by Material
3D Bioprinting Market, by Application
3D Bioprinting Market, by End User
11.3 Europe 75
3D Bioprinting Market, by Technology
3D Bioprinting Market, by Material
3D Bioprinting Market, by Application
3D Bioprinting Market, by End User
11.3.1 Western Europe 79
3D Bioprinting Market, by Technology
3D Bioprinting Market, by Material
3D Bioprinting Market, by Application
3D Bioprinting Market, by End User
11.3.1.1 Germany 83
3D Bioprinting Market, by Technology
3D Bioprinting Market, by Material
3D Bioprinting Market, by Application
3D Bioprinting Market, by End User
11.3.1.2 France 85
3D Bioprinting Market, by Technology
3D Bioprinting Market, by Material
3D Bioprinting Market, by Application
3D Bioprinting Market, by End User
11.3.1.3 U.K 88
3D Bioprinting Market, by Technology
3D Bioprinting Market, by Material
3D Bioprinting Market, by Application
3D Bioprinting Market, by End User
11.3.1.4 Italy 90
3D Bioprinting Market, by Technology
3D Bioprinting Market, by Material
3D Bioprinting Market, by Application
3D Bioprinting Market, by End User
11.3.1.5 Spain 93
3D Bioprinting Market, by Technology
3D Bioprinting Market, by Material
3D Bioprinting Market, by Application
3D Bioprinting Market, by End User
11.3.1.6 Rest of Western Europe 95
3D Bioprinting Market, by Technology
3D Bioprinting Market, by Material
3D Bioprinting Market, by Application
3D Bioprinting Market, by End User
11.3.2 Eastern Europe 98
3D Bioprinting Market, by Technology
3D Bioprinting Market, by Material
3D Bioprinting Market, by Application
3D Bioprinting Market, by End User
11.4 Asia-Pacific 101
3D Bioprinting Market, by Technology
3D Bioprinting Market, by Material
3D Bioprinting Market, by Application
3D Bioprinting Market, by End User
11.4.1 Japan 105
3D Bioprinting Market, by Technology
3D Bioprinting Market, by Material
3D Bioprinting Market, by Application
3D Bioprinting Market, by End User
11.4.2 China 108
3D Bioprinting Market, by Technology
3D Bioprinting Market, by Material
3D Bioprinting Market, by Application
3D Bioprinting Market, by End User
11.4.3 India 111
3D Bioprinting Market, by Technology
3D Bioprinting Market, by Material
3D Bioprinting Market, by Application
3D Bioprinting Market, by End User
11.4.4 Australia 114
3D Bioprinting Market, by Technology
3D Bioprinting Market, by Material
3D Bioprinting Market, by Application
3D Bioprinting Market, by End User
11.4.5 South Korea 116
3D Bioprinting Market, by Technology
3D Bioprinting Market, by Material
3D Bioprinting Market, by Application
3D Bioprinting Market, by End User
11.4.6 Rest of Asia–Pacific 119
3D Bioprinting Market, by Technology
3D Bioprinting Market, by Material
3D Bioprinting Market, by Application
3D Bioprinting Market, by End User
11.5 Middle East and Africa 122
3D Bioprinting Market, by Technology
3D Bioprinting Market, by Material
3D Bioprinting Market, by Application
3D Bioprinting Market, by End User
11.5.1 Middle East 126
3D Bioprinting Market, by Technology
3D Bioprinting Market, by Material
3D Bioprinting Market, by Application
3D Bioprinting Market, by End User
11.5.2 Africa 129
3D Bioprinting Market, by Technology
3D Bioprinting Market, by Material
3D Bioprinting Market, by Application
3D Bioprinting Market, by End User
12 Competitive Landscape
12.1 Introduction 133
12.2 Company Ranking 133
13 Company Profiles
13.1 Organovo Holdings Inc. 135
13.1.1 Company Overview 135
13.1.2 Financial Overview 135
13.1.3 Products/Services Offered 136
13.1.4 Key Developments 136
13.1.5 SWOT Analysis 136
13.1.6 Key Strategy 136
13.2 Cellink AB 137
13.2.1 Company Overview 137
13.2.2 Financial Overview 137
13.2.3 Products/Services Offered 138
13.2.4 Key Developments 138
13.2.5 SWOT Analysis 138
13.2.6 Key Strategy 139
13.3 Stratasys Ltd 140
13.3.1 Company Overview 140
13.3.2 Financial Overview 140
13.3.3 Products/Services Offered 141
13.3.4 Key Developments 141
13.3.5 SWOT Analysis 141
13.3.6 Key Strategy 141
13.4 FUJIFILM Wako Automation Corporation 142
13.4.1 Company Overview 142
13.4.2 Financial Overview 142
13.4.3 Products/Services Offered 143
13.4.4 Key Developments 143
13.4.5 SWOT Analysis 143
13.4.6 Key Strategy 143
13.5 Envisiontec GMBH 144
13.5.1 Company Overview 144
13.5.2 Financial Overview 144
13.5.3 Products/Services Offered 144
13.5.4 Key Developments 144
13.5.5 SWOT Analysis 145
13.5.6 Key Strategy 145
13.6 Nano3D Biosciences Inc. 146
13.6.1 Company Overview 146
13.6.2 Financial Overview 146
13.6.3 Products/Services Offered 146
13.6.4 Key Developments 146
13.6.5 SWOT Analysis 147
13.6.6 Key Strategy 147
13.7 Allevi 148
13.7.1 Company Overview 148
13.7.2 Financial Overview 148
13.7.3 Products/Services Offered 148
13.7.4 Key Developments 148
13.7.5 SWOT Analysis 149
13.7.6 Key Strategy 149
13.8 Cyfuse Biomedical K.K. 150
13.8.1 Company Overview 150
13.8.2 Financial Overview 150
13.8.3 Products/Services Offered 150
13.8.4 Key Developments 150
13.8.5 SWOT Analysis 150
13.8.6 Key Strategy 151
13.9 REGENHU LTD 152
13.9.1 Company Overview 152
13.9.2 Financial Overview 152
13.9.3 Products/Services Offered 152
13.9.4 Key Developments 152
13.9.5 SWOT Analysis 153
13.9.6 Key Strategy 153
13.10 Aspect Biosystems Ltd 154
13.10.1 Company Overview 154
13.10.2 Financial Overview 154
13.10.3 Products/Services Offered 154
13.10.4 Key Developments 154
13.10.5 SWOT Analysis 155
13.10.6 Key Strategy 155
13.11 Regenovo Biotechnology Co. Ltd. 156
13.11.1 Company Overview 156
13.11.2 Financial Overview 156
13.11.3 Products/Services Offered 156
13.11.4 Key Developments 156
13.11.5 SWOT Analysis 157
13.11.6 Key Strategy 157
13.12 Poietis 158
13.12.1 Company Overview 158
13.12.2 Financial Overview 158
13.12.3 Products/Services Offered 158
13.12.4 Key Developments 158
13.12.5 SWOT Analysis 159
13.12.6 Key Strategy 159
14 Appendix
14.1 Discussion Blue Print 161
15 List of Tables
TABLE 1 MARKET SYNOPSIS 18
TABLE 2 PRIMARY INTERVIEWS 22
TABLE 3 GLOBAL 3D BIOPRINTING MARKET BY TECHNOLOGY, 2022-2030 (USD MILLION) 38
TABLE 4 GLOBAL 3D BIOPRINTING MARKET FOR MICROEXTRUSION BIOPRINTING BY REGION, 2022-2030 (USD MILLION) 38
TABLE 5 GLOBAL 3D BIOPRINTING MARKET FOR INKJET 3D BIOPRINTING BY REGION, 2022-2030 (USD MILLION) 39
TABLE 6 GLOBAL 3D BIOPRINTING MARKET FOR LASER-ASSISTED BIOPRINTING BY REGION, 2022-2030 (USD MILLION) 40
TABLE 7 GLOBAL 3D BIOPRINTING MARKET FOR MAGNETIC 3D BIOPRINTING BY REGION, 2022-2030 (USD MILLION) 40
TABLE 8 GLOBAL 3D BIOPRINTING MARKET BY MATERIAL, 2022-2030 (USD MILLION) 43
TABLE 9 GLOBAL 3D BIOPRINTING MARKET FOR LIVING CELLS BY REGION, 2022-2030 (USD MILLION) 43
TABLE 10 GLOBAL 3D BIOPRINTING MARKET FOR HYDROGELS BY REGION, 2022-2030 (USD MILLION) 44
TABLE 11 GLOBAL 3D BIOPRINTING MARKET FOR EXTRACELLULAR MATRICES BY REGION, 2022-2030 (USD MILLION) 45
TABLE 12 GLOBAL 3D BIOPRINTING MARKET BY APPLICATION, 2022-2030 (USD MILLION) 47
TABLE 13 GLOBAL 3D BIOPRINTING MARKET FOR RESEARCH APPLICATIONS BY TYPE, 2022-2030 (USD MILLION) 48
TABLE 14 GLOBAL 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS BY TYPE, 2022-2030 (USD MILLION) 48
TABLE 15 GLOBAL 3D BIOPRINTING MARKET FOR RESEARCH APPLICATIONS BY REGION, 2022-2030 (USD MILLION) 49
TABLE 16 GLOBAL 3D BIOPRINTING MARKET FOR DRUG RESEARCH BY REGION, 2022-2030 (USD MILLION) 49
TABLE 17 GLOBAL 3D BIOPRINTING MARKET FOR REGENERATIVE MEDICINE & TISSUE ENGINEERING BY REGION, 2022-2030
(USD MILLION) 50
TABLE 18 GLOBAL 3D BIOPRINTING MARKET FOR 3D CELL CULTURE BY REGION, 2022-2030 (USD MILLION) 50
TABLE 19 GLOBAL 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS BY REGION, 2022-2030 (USD MILLION) 51
TABLE 20 GLOBAL 3D BIOPRINTING MARKET FOR SKIN BY REGION, 2022-2030 (USD MILLION) 51
TABLE 21 GLOBAL 3D BIOPRINTING MARKET FOR DENTAL BY REGION, 2022-2030 (USD MILLION) 52
TABLE 22 GLOBAL 3D BIOPRINTING MARKET FOR BONE BY REGION, 2022-2030 (USD MILLION) 52
TABLE 23 GLOBAL 3D BIOPRINTING MARKET BY END USER, 2022-2030 (USD MILLION) 55
TABLE 24 GLOBAL 3D BIOPRINTING MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2022-2030
(USD MILLION) 55
TABLE 25 GLOBAL 3D BIOPRINTING MARKET FOR RESEARCH ORGANIZATIONS & ACADEMIC INSTITUTES, BY REGION, 2022-2030
(USD MILLION) 56
TABLE 26 GLOBAL 3D BIOPRINTING MARKET, BY REGION, 2022-2030 (USD MILLION) 59
TABLE 27 AMERICAS: 3D BIOPRINTING MARKET, BY REGION, 2022-2030 (USD MILLION) 60
TABLE 28 AMERICAS: 3D BIOPRINTING MARKET, BY TECHNOLOGY, 2022-2030 (USD MILLION) 61
TABLE 29 AMERICAS: 3D BIOPRINTING MARKET, BY MATERIAL, 2022-2030 (USD MILLION) 61
TABLE 30 AMERICAS: 3D BIOPRINTING MARKET, BY APPLICATION, 2022-2030 (USD MILLION) 62
TABLE 31 AMERICAS: 3D BIOPRINTING MARKET FOR RESEARCH APPLICATION BY TYPE, 2022-2030 (USD MILLION) 62
TABLE 32 AMERICAS: 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS BY TYPE, 2022-2030 (USD MILLION) 62
TABLE 33 AMERICAS: 3D BIOPRINTING MARKET, BY END USER, 2022-2030 (USD MILLION) 63
TABLE 34 NORTH AMERICA: 3D BIOPRINTING MARKET, BY COUNTRY, 2022-2030 (USD MILLION) 64
TABLE 35 NORTH AMERICA: 3D BIOPRINTING MARKET, BY TECHNOLOGY, 2022-2030 (USD MILLION) 64
TABLE 36 NORTH AMERICA: 3D BIOPRINTING MARKET, BY MATERIAL, 2022-2030 (USD MILLION) 65
TABLE 37 NORTH AMERICA: 3D BIOPRINTING MARKET, BY APPLICATION, 2022-2030 (USD MILLION) 65
TABLE 38 NORTH AMERICA: 3D BIOPRINTING MARKET FOR RESEARCH APPLICATION BY TYPE, 2022-2030 (USD MILLION) 65
TABLE 39 NORTH AMERICA: 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS BY TYPE, 2022-2030 (USD MILLION) 66
TABLE 40 NORTH AMERICA: 3D BIOPRINTING MARKET, BY END USER, 2022-2030 (USD MILLION) 66
TABLE 41 US: 3D BIOPRINTING MARKET, BY TECHNOLOGY, 2022-2030 (USD MILLION) 67
TABLE 42 US: 3D BIOPRINTING MARKET, BY MATERIAL, 2022-2030 (USD MILLION) 67
TABLE 43 US: 3D BIOPRINTING MARKET, BY APPLICATION, 2022-2030 (USD MILLION) 68
TABLE 44 US: 3D BIOPRINTING MARKET FOR RESEARCH APPLICATION BY TYPE, 2022-2030 (USD MILLION) 68
TABLE 45 US: 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS BY TYPE, 2022-2030 (USD MILLION) 68
TABLE 46 US: 3D BIOPRINTING MARKET, BY END USER, 2022-2030 (USD MILLION) 69
TABLE 47 CANADA: 3D BIOPRINTING MARKET, BY TECHNOLOGY, 2022-2030 (USD MILLION) 69
TABLE 48 CANADA: 3D BIOPRINTING MARKET, BY MATERIAL, 2022-2030 (USD MILLION) 70
TABLE 49 CANADA: 3D BIOPRINTING MARKET, BY APPLICATION, 2022-2030 (USD MILLION) 70
TABLE 50 CANADA: 3D BIOPRINTING MARKET FOR RESEARCH APPLICATION BY TYPE, 2022-2030 (USD MILLION) 70
TABLE 51 CANADA: 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS BY TYPE, 2022-2030 (USD MILLION) 71
TABLE 52 CANADA: 3D BIOPRINTING MARKET, BY END USER, 2022-2030 (USD MILLION) 71
TABLE 53 SOUTH AMERICA: 3D BIOPRINTING MARKET, BY TECHNOLOGY, 2022-2030 (USD MILLION) 72
TABLE 54 SOUTH AMERICA: 3D BIOPRINTING MARKET, BY MATERIAL, 2022-2030 (USD MILLION) 72
TABLE 55 SOUTH AMERICA: 3D BIOPRINTING MARKET, BY APPLICATION, 2022-2030 (USD MILLION) 73
TABLE 56 SOUTH AMERICA: 3D BIOPRINTING MARKET FOR RESEARCH APPLICATION BY TYPE, 2022-2030 (USD MILLION) 73
TABLE 57 SOUTH AMERICA: 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS BY TYPE, 2022-2030 (USD MILLION) 73
TABLE 58 SOUTH AMERICA: 3D BIOPRINTING MARKET, BY END USER, 2022-2030 (USD MILLION) 74
TABLE 59 EUROPE: 3D BIOPRINTING MARKET, BY REGION, 2022-2030 (USD MILLION) 76
TABLE 60 EUROPE: 3D BIOPRINTING MARKET, BY TECHNOLOGY, 2022-2030 (USD MILLION) 76
TABLE 61 EUROPE: 3D BIOPRINTING MARKET, BY MATERIAL, 2022-2030 (USD MILLION) 77
TABLE 62 EUROPE: 3D BIOPRINTING MARKET, BY APPLICATION, 2022-2030 (USD MILLION) 77
TABLE 63 EUROPE: 3D BIOPRINTING MARKET FOR RESEARCH APPLICATION BY TYPE, 2022-2030 (USD MILLION) 77
TABLE 64 EUROPE: 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS BY TYPE, 2022-2030 (USD MILLION) 78
TABLE 65 EUROPE: 3D BIOPRINTING MARKET, BY END USER, 2022-2030 (USD MILLION) 78
TABLE 66 WESTERN EUROPE: 3D BIOPRINTING MARKET, BY COUNTRY, 2022-2030 (USD MILLION) 79
TABLE 67 WESTERN EUROPE: 3D BIOPRINTING MARKET, BY TECHNOLOGY, 2022-2030 (USD MILLION) 80
TABLE 68 WESTERN EUROPE: 3D BIOPRINTING MARKET, BY MATERIAL, 2022-2030 (USD MILLION) 80
TABLE 69 WESTERN EUROPE: 3D BIOPRINTING MARKET, BY APPLICATION, 2022-2030 (USD MILLION) 81
TABLE 70 WESTERN EUROPE: 3D BIOPRINTING MARKET FOR RESEARCH APPLICATION BY TYPE, 2022-2030 (USD MILLION) 81
TABLE 71 WESTERN EUROPE: 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS BY TYPE, 2022-2030 (USD MILLION) 81
TABLE 72 WESTERN EUROPE: 3D BIOPRINTING MARKET, BY END USER, 2022-2030 (USD MILLION) 82
TABLE 73 GERMANY: 3D BIOPRINTING MARKET, BY TECHNOLOGY, 2022-2030 (USD MILLION) 83
TABLE 74 GERMANY: 3D BIOPRINTING MARKET, BY MATERIAL, 2022-2030 (USD MILLION) 83
TABLE 75 GERMANY: 3D BIOPRINTING MARKET, BY APPLICATION, 2022-2030 (USD MILLION) 84
TABLE 76 GERMANY: 3D BIOPRINTING MARKET FOR RESEARCH APPLICATION BY TYPE, 2022-2030 (USD MILLION) 84
TABLE 77 GERMANY: 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS BY TYPE, 2022-2030 (USD MILLION) 84
TABLE 78 GERMANY: 3D BIOPRINTING MARKET, BY END USER, 2022-2030 (USD MILLION) 85
TABLE 79 FRANCE: 3D BIOPRINTING MARKET, BY TECHNOLOGY, 2022-2030 (USD MILLION) 85
TABLE 80 FRANCE: 3D BIOPRINTING MARKET, BY MATERIAL, 2022-2030 (USD MILLION) 86
TABLE 81 FRANCE: 3D BIOPRINTING MARKET, BY APPLICATION, 2022-2030 (USD MILLION) 86
TABLE 82 FRANCE: 3D BIOPRINTING MARKET FOR RESEARCH APPLICATION BY TYPE, 2022-2030 (USD MILLION) 86
TABLE 83 FRANCE: 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS BY TYPE, 2022-2030 (USD MILLION) 87
TABLE 84 FRANCE: 3D BIOPRINTING MARKET, BY END USER, 2022-2030 (USD MILLION) 87
TABLE 85 U.K: 3D BIOPRINTING MARKET, BY TECHNOLOGY, 2022-2030 (USD MILLION) 88
TABLE 86 U.K: 3D BIOPRINTING MARKET, BY MATERIAL, 2022-2030 (USD MILLION) 88
TABLE 87 U.K: 3D BIOPRINTING MARKET, BY APPLICATION, 2022-2030 (USD MILLION) 89
TABLE 88 U.K: 3D BIOPRINTING MARKET FOR RESEARCH APPLICATION BY TYPE, 2022-2030 (USD MILLION) 89
TABLE 89 U.K: 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS BY TYPE, 2022-2030 (USD MILLION) 89
TABLE 90 U.K: 3D BIOPRINTING MARKET, BY END USER, 2022-2030 (USD MILLION) 90
TABLE 91 ITALY: 3D BIOPRINTING MARKET, BY TECHNOLOGY, 2022-2030 (USD MILLION) 90
TABLE 92 ITALY: 3D BIOPRINTING MARKET, BY MATERIAL, 2022-2030 (USD MILLION) 91
TABLE 93 ITALY: 3D BIOPRINTING MARKET, BY APPLICATION, 2022-2030 (USD MILLION) 91
TABLE 94 ITALY: 3D BIOPRINTING MARKET FOR RESEARCH APPLICATION BY TYPE, 2022-2030 (USD MILLION) 91
TABLE 95 ITALY: 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS BY TYPE, 2022-2030 (USD MILLION) 92
TABLE 96 ITALY: 3D BIOPRINTING MARKET, BY END USER, 2022-2030 (USD MILLION) 92
TABLE 97 SPAIN: 3D BIOPRINTING MARKET, BY TECHNOLOGY, 2022-2030 (USD MILLION) 93
TABLE 98 SPAIN: 3D BIOPRINTING MARKET, BY MATERIAL, 2022-2030 (USD MILLION) 93
TABLE 99 SPAIN: 3D BIOPRINTING MARKET, BY APPLICATION, 2022-2030 (USD MILLION) 94
TABLE 100 SPAIN: 3D BIOPRINTING MARKET FOR RESEARCH APPLICATION BY TYPE, 2022-2030 (USD MILLION) 94
TABLE 101 SPAIN: 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS BY TYPE, 2022-2030 (USD MILLION) 94
TABLE 102 SPAIN: 3D BIOPRINTING MARKET, BY END USER, 2022-2030 (USD MILLION) 95
TABLE 103 REST OF WESTERN EUROPE: 3D BIOPRINTING MARKET, BY TECHNOLOGY, 2022-2030 (USD MILLION) 95
TABLE 104 REST OF WESTERN EUROPE: 3D BIOPRINTING MARKET, BY MATERIAL, 2022-2030 (USD MILLION) 96
TABLE 105 REST OF WESTERN EUROPE: 3D BIOPRINTING MARKET, BY APPLICATION, 2022-2030 (USD MILLION) 96
TABLE 106 REST OF WESTERN EUROPE: 3D BIOPRINTING MARKET FOR RESEARCH APPLICATION BY TYPE, 2022-2030 (USD MILLION) 97
TABLE 107 REST OF WESTERN EUROPE: 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS BY TYPE, 2022-2030 (USD MILLION) 97
TABLE 108 REST OF WESTERN EUROPE: 3D BIOPRINTING MARKET, BY END USER, 2022-2030 (USD MILLION) 98
TABLE 109 EASTERN EUROPE: 3D BIOPRINTING MARKET, BY TECHNOLOGY, 2022-2030 (USD MILLION) 98
TABLE 110 EASTERN EUROPE: 3D BIOPRINTING MARKET, BY MATERIAL, 2022-2030 (USD MILLION) 99
TABLE 111 EASTERN EUROPE: 3D BIOPRINTING MARKET, BY APPLICATION, 2022-2030 (USD MILLION) 99
TABLE 112 EASTERN EUROPE: 3D BIOPRINTING MARKET FOR RESEARCH APPLICATION BY TYPE, 2022-2030 (USD MILLION) 99
TABLE 113 EASTERN EUROPE: 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS BY TYPE, 2022-2030 (USD MILLION) 100
TABLE 114 EASTERN EUROPE: 3D BIOPRINTING MARKET, BY END USER, 2022-2030 (USD MILLION) 100
TABLE 115 ASIA-PACIFIC: 3D BIOPRINTING MARKET, BY COUNTRY, 2022-2030 (USD MILLION) 102
TABLE 116 ASIA-PACIFIC: 3D BIOPRINTING MARKET, BY TECHNOLOGY, 2022-2030 (USD MILLION) 102
TABLE 117 ASIA-PACIFIC: 3D BIOPRINTING MARKET, BY MATERIAL, 2022-2030 (USD MILLION) 103
TABLE 118 ASIA-PACIFIC: 3D BIOPRINTING MARKET, BY APPLICATION, 2022-2030 (USD MILLION) 103
TABLE 119 ASIA-PACIFIC: 3D BIOPRINTING MARKET FOR RESEARCH APPLICATION BY TYPE, 2022-2030 (USD MILLION) 103
TABLE 120 ASIA-PACIFIC: 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS BY TYPE, 2022-2030 (USD MILLION) 104
TABLE 121 ASIA-PACIFIC: 3D BIOPRINTING MARKET, BY END USER, 2022-2030 (USD MILLION) 104
TABLE 122 JAPAN: 3D BIOPRINTING MARKET, BY TECHNOLOGY, 2022-2030 (USD MILLION) 105
TABLE 123 JAPAN: 3D BIOPRINTING MARKET, BY MATERIAL, 2022-2030 (USD MILLION) 105
TABLE 124 JAPAN: 3D BIOPRINTING MARKET, BY APPLICATION, 2022-2030 (USD MILLION) 106
TABLE 125 JAPAN: 3D BIOPRINTING MARKET FOR RESEARCH APPLICATION BY TYPE, 2022-2030 (USD MILLION) 106
TABLE 126 JAPAN: 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS BY TYPE, 2022-2030 (USD MILLION) 106
TABLE 127 JAPAN: 3D BIOPRINTING MARKET, BY END USER, 2022-2030 (USD MILLION) 107
TABLE 128 CHINA: 3D BIOPRINTING MARKET, BY TECHNOLOGY, 2022-2030 (USD MILLION) 108
TABLE 129 CHINA: 3D BIOPRINTING MARKET, BY MATERIAL, 2022-2030 (USD MILLION) 108
TABLE 130 CHINA: 3D BIOPRINTING MARKET, BY APPLICATION, 2022-2030 (USD MILLION) 109
TABLE 131 CHINA: 3D BIOPRINTING MARKET FOR RESEARCH APPLICATION BY TYPE, 2022-2030 (USD MILLION) 109
TABLE 132 CHINA: 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS BY TYPE, 2022-2030 (USD MILLION) 109
TABLE 133 CHINA: 3D BIOPRINTING MARKET, BY END USER, 2022-2030 (USD MILLION) 110
TABLE 134 INDIA: 3D BIOPRINTING MARKET, BY TECHNOLOGY, 2022-2030 (USD MILLION) 111
TABLE 135 INDIA: 3D BIOPRINTING MARKET, BY MATERIAL, 2022-2030 (USD MILLION) 111
TABLE 136 INDIA: 3D BIOPRINTING MARKET, BY APPLICATION, 2022-2030 (USD MILLION) 112
TABLE 137 INDIA: 3D BIOPRINTING MARKET FOR RESEARCH APPLICATION BY TYPE, 2022-2030 (USD MILLION) 112
TABLE 138 INDIA: 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS BY TYPE, 2022-2030 (USD MILLION) 112
TABLE 139 INDIA: 3D BIOPRINTING MARKET, BY END USER, 2022-2030 (USD MILLION) 113
TABLE 140 AUSTRALIA: 3D BIOPRINTING MARKET, BY TECHNOLOGY, 2022-2030 (USD MILLION) 114
TABLE 141 AUSTRALIA: 3D BIOPRINTING MARKET, BY MATERIAL, 2022-2030 (USD MILLION) 114
TABLE 142 AUSTRALIA: 3D BIOPRINTING MARKET, BY APPLICATION, 2022-2030 (USD MILLION) 115
TABLE 143 AUSTRALIA: 3D BIOPRINTING MARKET FOR RESEARCH APPLICATION BY TYPE, 2022-2030 (USD MILLION) 115
TABLE 144 AUSTRALIA: 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS BY TYPE, 2022-2030 (USD MILLION) 115
TABLE 145 AUSTRALIA: 3D BIOPRINTING MARKET, BY END USER, 2022-2030 (USD MILLION) 116
TABLE 146 SOUTH KOREA: 3D BIOPRINTING MARKET, BY TECHNOLOGY, 2022-2030 (USD MILLION) 116
TABLE 147 SOUTH KOREA: 3D BIOPRINTING MARKET, BY MATERIAL, 2022-2030 (USD MILLION) 117
TABLE 148 SOUTH KOREA: 3D BIOPRINTING MARKET, BY APPLICATION, 2022-2030 (USD MILLION) 117
TABLE 149 SOUTH KOREA: 3D BIOPRINTING MARKET FOR RESEARCH APPLICATION BY TYPE, 2022-2030 (USD MILLION) 117
TABLE 150 SOUTH KOREA: 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS BY TYPE, 2022-2030 (USD MILLION) 118
TABLE 151 SOUTH KOREA: 3D BIOPRINTING MARKET, BY END USER, 2022-2030 (USD MILLION) 118
TABLE 152 REST OF ASIA–PACIFIC: 3D BIOPRINTING MARKET, BY TECHNOLOGY, 2022-2030 (USD MILLION) 119
TABLE 153 REST OF ASIA–PACIFIC: 3D BIOPRINTING MARKET, BY MATERIAL, 2022-2030 (USD MILLION) 119
TABLE 154 REST OF ASIA–PACIFIC: 3D BIOPRINTING MARKET, BY APPLICATION, 2022-2030 (USD MILLION) 120
TABLE 155 REST OF ASIA–PACIFIC: 3D BIOPRINTING MARKET FOR RESEARCH APPLICATION BY TYPE, 2022-2030 (USD MILLION) 120
TABLE 156 REST OF ASIA–PACIFIC: 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS BY TYPE, 2022-2030 (USD MILLION) 120
TABLE 157 REST OF ASIA–PACIFIC: 3D BIOPRINTING MARKET, BY END USER, 2022-2030 (USD MILLION) 121
TABLE 158 MIDDLE EAST AND AFRICA: 3D BIOPRINTING MARKET, BY REGION, 2022-2030 (USD MILLION) 122
TABLE 159 MIDDLE EAST AND AFRICA: 3D BIOPRINTING MARKET, BY TECHNOLOGY, 2022-2030 (USD MILLION) 123
TABLE 160 MIDDLE EAST AND AFRICA: 3D BIOPRINTING MARKET, BY MATERIAL, 2022-2030 (USD MILLION) 123
TABLE 161 MIDDLE EAST AND AFRICA: 3D BIOPRINTING MARKET, BY APPLICATION, 2022-2030 (USD MILLION) 124
TABLE 162 MIDDLE EAST AND AFRICA: 3D BIOPRINTING MARKET FOR RESEARCH APPLICATION BY TYPE, 2022-2030 (USD MILLION) 124
TABLE 163 MIDDLE EAST AND AFRICA: 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS BY TYPE, 2022-2030 (USD MILLION) 124
TABLE 164 MIDDLE EAST AND AFRICA: 3D BIOPRINTING MARKET, BY END USER, 2022-2030 (USD MILLION) 125
TABLE 165 MIDDLE EAST: 3D BIOPRINTING MARKET, BY TECHNOLOGY, 2022-2030 (USD MILLION) 126
TABLE 166 MIDDLE EAST: 3D BIOPRINTING MARKET, BY MATERIAL, 2022-2030 (USD MILLION) 126
TABLE 167 MIDDLE EAST: 3D BIOPRINTING MARKET, BY APPLICATION, 2022-2030 (USD MILLION) 127
TABLE 168 MIDDLE EAST: 3D BIOPRINTING MARKET FOR RESEARCH APPLICATION BY TYPE, 2022-2030 (USD MILLION) 127
TABLE 169 MIDDLE EAST: 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS BY TYPE, 2022-2030 (USD MILLION) 127
TABLE 170 MIDDLE EAST: 3D BIOPRINTING MARKET, BY END USER, 2022-2030 (USD MILLION) 128
TABLE 171 AFRICA: 3D BIOPRINTING MARKET, BY TECHNOLOGY, 2022-2030 (USD MILLION) 129
TABLE 172 AFRICA: 3D BIOPRINTING MARKET, BY MATERIAL, 2022-2030 (USD MILLION) 129
TABLE 173 AFRICA: 3D BIOPRINTING MARKET, BY APPLICATION, 2022-2030 (USD MILLION) 130
TABLE 174 AFRICA: 3D BIOPRINTING MARKET FOR RESEARCH APPLICATION BY TYPE, 2022-2030 (USD MILLION) 130
TABLE 175 AFRICA: 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS BY TYPE, 2022-2030 (USD MILLION) 130
TABLE 176 AFRICA: 3D BIOPRINTING MARKET, BY END USER, 2022-2030 (USD MILLION) 131
16 List of Figures
FIGURE 1 RESEARCH PROCESS 21
FIGURE 2 TOP-DOWN & BOTTOM-UP APPROACH 26
FIGURE 3 MARKET DYNAMICS: ANALYSIS OF THE GLOBAL 3D BIOPRINTING MARKET 28
FIGURE 4 PORTER’S FIVE FORCES ANALYSIS: GLOBAL 3D BIOPRINTING MARKET 32
FIGURE 5 SUPPLY CHAIN: GLOBAL 3D BIOPRINTING MARKET 34
FIGURE 6 GLOBAL 3D BIOPRINTING MARKET SHARE, BY TECHNOLOGY, 2022 (%) 37
FIGURE 7 GLOBAL 3D BIOPRINTING MARKET, BY TECHNOLOGY, 2022 & 2030 (USD MILLION) 37
FIGURE 8 GLOBAL 3D BIOPRINTING MARKET SHARE, BY MATERIAL, 2022 (%) 42
FIGURE 9 GLOBAL 3D BIOPRINTING MARKET, BY MATERIAL, 2022 & 2030 (USD MILLION) 42
FIGURE 10 GLOBAL 3D BIOPRINTING MARKET SHARE, BY APPLICATION, 2022 (%) 47
FIGURE 11 GLOBAL 3D BIOPRINTING MARKET, BY APPLICATION, 2022 & 2030 (USD MILLION) 47
FIGURE 12 GLOBAL 3D BIOPRINTING MARKET SHARE, BY END USER, 2022 (%) 54
FIGURE 13 GLOBAL 3D BIOPRINTING MARKET, BY END USER, 2022 & 2030 (USD MILLION) 54
FIGURE 14 GLOBAL 3D BIOPRINTING MARKET, BY REGION, 2022 & 2030 (USD MILLION) 58
FIGURE 15 GLOBAL 3D BIOPRINTING MARKET SHARE, BY REGION, 2022 (%) 59
FIGURE 16 AMERICAS: 3D BIOPRINTING MARKET SHARE, BY REGION, 2022 (%) 60
FIGURE 17 NORTH AMERICA: 3D BIOPRINTING MARKET SHARE, BY COUNTRY, 2022 (%) 63
FIGURE 18 EUROPE: 3D BIOPRINTING MARKET SHARE, BY REGION, 2022 (%) 75
FIGURE 19 WESTERN EUROPE: 3D BIOPRINTING MARKET SHARE, BY COUNTRY, 2022 (%) 79
FIGURE 20 ASIA-PACIFIC: 3D BIOPRINTING MARKET SHARE, BY COUNTRY, 2022 (%) 101
FIGURE 21 MIDDLE EAST AND AFRICA: 3D BIOPRINTING MARKET SHARE, BY REGION, 2022 (%) 122